Sign in

CIK 0001743881

  • Large accelerated filer

BridgeBio Pharma, Inc.

Sign in to watch
Ticker
BBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 650-391-9740
Business address
3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
Former names
BridgeBio Pharma LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,117,307
in 3 filings, $5.1M under 10b5-1 plans

Net −$5,117,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-19 Kumar Neil Chief Executive Officer Sale 10b5-1 −8,500 $78.35 $666K 477,186
2026-11-19 Kumar Neil Chief Executive Officer Sale 10b5-1 −1,500 $79.29 $119K 475,686
2026-11-18 Kumar Neil Chief Executive Officer Sale 10b5-1 −4,490 $76.99 $346K 273,817
2026-11-18 Kumar Neil Chief Executive Officer Sale 10b5-1 −30,490 $77.83 $2.4M 243,327
2026-11-18 Kumar Neil Chief Executive Officer Sale 10b5-1 −1,277 $76.99 $98K 494,409
2026-11-18 Kumar Neil Chief Executive Officer Sale 10b5-1 −8,723 $77.83 $679K 485,686
2026-11-16 Trimarchi Thomas President and CFO Shares withheld for taxes −22,781 $77.36 $1.8M 313,748
2026-11-16 Apuli Maricel Chief Accounting Officer Shares withheld for taxes −4,714 $77.36 $365K 115,973
2026-11-16 Kumar Neil Chief Executive Officer Exercise or conversion +33,544 276,871
2026-11-16 Kumar Neil Chief Executive Officer Exercise or conversion +19,599 296,470
2026-11-16 Kumar Neil Chief Executive Officer Exercise or conversion +11,554 308,024
2026-11-16 Kumar Neil Chief Executive Officer Exercise or conversion +6,519 314,543
2026-11-16 Kumar Neil Chief Executive Officer Shares withheld for taxes −36,236 $77.36 $2.8M 278,307
2026-11-16 Kumar Neil Chief Executive Officer Exercise or conversion · Restricted Stock Units −33,544 33,544
2026-11-16 Kumar Neil Chief Executive Officer Exercise or conversion · Restricted Stock Units −19,599 97,997
2026-11-16 Kumar Neil Chief Executive Officer Exercise or conversion · Restricted Stock Units −11,554 103,984
2026-11-16 Kumar Neil Chief Executive Officer Exercise or conversion · Restricted Stock Units −6,519 84,755
2026-10-30 Apuli Maricel Chief Accounting Officer Sale 10b5-1 −2,000 $72.85 $146K 120,687
2026-09-17 Kumar Neil Chief Executive Officer Sale 10b5-1 −8,721 $69.01 $602K 496,965
2026-09-17 Kumar Neil Chief Executive Officer Sale 10b5-1 −1,279 $69.57 $89K 495,686

Page 1 of 61 · 1,201 trades